An assessment of reliability and validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 among breast cancer patients in Qatar

Abdulbari Bener, Reem Alsulaiman, Lisa Doodson, Hanadi R El Ayoubi, Abdulbari Bener, Reem Alsulaiman, Lisa Doodson, Hanadi R El Ayoubi

Abstract

Introduction: Breast cancer has been the most common cancer type that affects women worldwide and subsequent treatment is often associated with considerable psychological and quality of life (QoL).

Aim: This study aimed to assess psychometric properties of the Arabic version of the European Organization for Research and Treatment of Cancer (EORTC) general QoL questionnaire (QLQ-C30) for breast cancer patients in Qatar.

Materials and methods: This is a cross-sectional hospital-based study conducted on 678 breast cancer patients using Arabic version of the EORTC QLQ-C30 tool.

Results: The mean age of women was 47.7 ± 10.2 years and 33.4% of women had consanguineous parents. Six subscales out of the nine met the standards of reliability with coefficients ranging from 0.55 to 0.89. The mean score of all functioning scales was high >55. Advanced breast cancer stages of III-IV had higher symptomatic scores significantly than those in early stages for the physical function, cognitive, fatigue, insomnia, appetite loss, constipation, and financial difficulties. Correlation coefficients between each item ranged from -0.113 to 0.960, and item 21 (tense) and item 23 (irritable) had strongest negative correlations with their corresponding emotional functioning subscale, whereas items 29 (physical condition) and 30 (overall QoL) had the strongest positive correlation with Global Health/QoL subscale. Item 6 (limited work) showed a higher correlation with fatigue (r = 0.749). Likewise, item 19 (pain interfered with daily activities) of the pain subscale had higher correlations with physical functioning, role functioning, and fatigue subscales.

Conclusion: Qatari Arabic version of the EORTC QLQ-C30 showed acceptable psychometric properties, which is a reliable and valid instrument, that can be used by oncologists.

Keywords: European Organization for Research and Treatment of Cancer and Quality of Life Questionnaire-C30; functional scale; internal consistency; oncology; quality of life; symptom scale; women.

Conflict of interest statement

There are no conflicts of interest.

References

    1. World Health Organization. The Global Burden of Disease. Geneva, Switzerland: WHO Press; 2014. [Last accessed on 2016 Nov 25]. Available from:
    1. Globocan cancer fact sheet. Breast Cancer Incidence and Mortality Worldwide in 2017. [Last accessed on 2017 Sep 28]. Available from: .
    1. Bener A, El Ayoubi HR. The role of Vitamin D deficiency and osteoporosis in breast cancer. Int J Rheum Dis. 2012;15:554–61.
    1. Bener A, Zirie MA, Kim EJ, Al Buz R, Zaza M, Al-Nufal M, et al. Measuring burden of diseases in a rapidly developing economy: State of Qatar. Glob J Health Sci. 2012;5:134–44.
    1. Bener A, Alsulaiman R, Doodson L. Comparison of reliability and validity of breast cancer depression, anxiety stress scales (DASS21) with Beck Depression, inventory-(BDI-II) and hospital anxiety and depression scale (HADS) Int J Behav Res Psychol. 2016;4:197–203.
    1. Koopman C, Angell K, Turner-Cobb JM, Kreshka MA, Donnelly P, McCoy R, et al. Distress, coping, and social support among rural women recently diagnosed with primary breast cancer. Breast J. 2001;7:25–33.
    1. Knobf MT. Psychosocial responses in breast cancer survivors. Semin Oncol Nurs. 2007;23:71–83.
    1. Helgeson VS, Snyder P, Seltman H. Psychological and physical adjustment to breast cancer over 4 years: Identifying distinct trajectories of change. Health Psychol. 2004;23:3–15.
    1. Shuleta-Qehaja S, Sterjev Z, Shuturkova L. Evaluation of reliability and validity of the European organization for research and treatment of cancer quality of life questionnaire (EORTC QLQ-C30, Albanian version) among breast cancer patients from Kosovo. Patient Prefer Adherence. 2015;9:459–65.
    1. Ahn SH, Park BW, Noh DY, Nam SJ, Lee ES, Lee MK, et al. Health-related quality of life in disease-free survivors of breast cancer with the general population. Ann Oncol. 2007;18:173–82.
    1. Cull A, Sprangers M, Bjordal K, Aaronson N, West K, Bottomley A. Guidelines for Translating EORTC Questionnaires. Brussels, Belgium: Quality of Life Study Group Publications, EORTC Publication; 2002.
    1. Fayers P, Bottomley A, EORTC Quality of Life Group. Quality of Life Unit Quality of life research within the EORTC-the EORTC QLQ-C30. European organisation for research and treatment of cancer. Eur J Cancer. 2002;38 Suppl 4:S125–33.
    1. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, EORTC Quality of Life Group . 3rd ed. Brussels, Belgium: European Organisation for Research and Treatment of Cancer; 2001. The EORTC QLQ-C30 Scoring Manual.
    1. EORTC QLQ-C30. Brussels, Belgium: EORTC Quality of Life Department; [Last accessed on 2016 Nov 26]. Available from: .
    1. Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, et al. Vol. 10. Lyon, France: International Agency for research on Cancer (IARC) and World Health Organization (WHO) Pub # 164; 2013. Cancer incidence in five continents; p. 616.
    1. Bener A, Ayub H, Kakil R, Ibrahim W. Patterns of cancer incidence among the population of Qatar: A worldwide comparative study. Asian Pac J Cancer Prev. 2008;9:19–24.
    1. Bener A, Ayoubi HR, Ali AI, Al-Kubaisi A, Al-Sulaiti H. Does consanguinity lead to decreased incidence of breast cancer? Cancer Epidemiol. 2010;34:413–8.
    1. Waldmann A, Pritzkuleit R, Raspe H, Katalinic A. The OVIS study: Health related quality of life measured by the EORTC QLQ-C30 and -BR23 in German female patients with breast cancer from Schleswig-Holstein. Qual Life Res. 2007;16:767–76.
    1. Huijer HA, Sagherian K, Tamim H. Validation of the Arabic version of the EORTC quality of life questionnaire among cancer patients in Lebanon. Qual Life Res. 2013;22:1473–81.
    1. Awad MA, Denic S, El Taji H. Validation of the European organization for research and treatment of cancer quality of life questionnaires for Arabic-speaking populations. Ann N Y Acad Sci. 2008;1138:146–54.
    1. Alawadhi SA, Ohaeri JU. Validity and reliability of the European organization for research and treatment in cancer quality of life questionnaire (EORTC QLQ): Experience from Kuwait using a sample of women with breast cancer. Ann Saudi Med. 2010;30:390–6.
    1. Hoopman R, Muller MJ, Terwee CB, Aaronson NK. Translation and validation of the EORTC QLQ-C30 for use among Turkish and Moroccan ethnic minority cancer patients in the Netherlands. Eur J Cancer. 2006;42:1839–47.
    1. Kontodimopoulos N, Ntinoulis K, Niakas D. Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients. Eur J Cancer Care (Engl) 2011;20:354–61.
    1. Cankurtaran ES, Ozalp E, Soygur H, Ozer S, Akbiyik DI, Bottomley A, et al. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients. Eur J Cancer Care (Engl) 2008;17:98–104.
    1. Guzelant A, Goksel T, Ozkok S, Tasbakan S, Aysan T, Bottomley A, et al. The European organization for research and treatment of cancer QLQ-C30: An examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30. Eur J Cancer Care (Engl) 2004;13:135–44.
    1. Michelson H, Bolund C, Nilsson B, Brandberg Y. Health-related quality of life measured by the EORTC QLQ-C30 – Reference values from a large sample of Swedish population. Acta Oncol. 2000;39:477–84.
    1. Tan ML, Idris DB, Teo LW, Loh SY, Seow GC, Chia YY, et al. Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore. Asia Pac J Oncol Nurs. 2014;1:22–32.
    1. Snyder CF, Blackford AL, Okuyama T, Akechi T, Yamashita H, Toyama T, et al. Using the EORTC-QLQ-C30 in clinical practice for patient management: Identifying scores requiring a clinician's attention. Qual Life Res. 2013;22:2685–91.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren